Provided by Tiger Trade Technology Pte. Ltd.

Amgen

402.59
-10.4950-2.54%
Volume:447.79K
Turnover:181.04M
Market Cap:216.78B
PE:25.01
High:411.84
Open:410.01
Low:400.06
Close:413.08
52wk High:447.03
52wk Low:288.00
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.56
T/O Rate:0.08%
Dividend:9.80
Dividend Rate:2.43%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:18.55
PE(LYR):28.29

Loading ...

Amgen Says Dazodalibep Meets Primary Endpoint in Phase 3 Sjögren's Disease Trial

Reuters
·
Sep 22

Movement Alert|Amgen Rises 3.39% in Regular Trading, Dazodalibep Phase 3 Trial in Sjogren Disease Delivers Positive Results

Market Focus
·
Sep 22

Amgen Shares up 3% After Co's Autoimmune Disease Drug Succeeds in Late-Stage Trial

THOMSON REUTERS
·
Sep 22

Movement Alert|Amgen Rises 4.79% in Pre-Market Trading, Dazodalibep Phase 3 Trial in Sjogren Disease Delivers Positive Results

Market Focus
·
Sep 22

Amgen Says Phase 3 Trial Shows Dazodalibep Cuts Systemic Disease Activity in Sjögren’s Disease

Reuters
·
Sep 22

Amgen Announces Positive Topline Phase 3 Results for Dazodalibep in Moderate-to-Severe Systemic SjÖGren's Disease

THOMSON REUTERS
·
Sep 22

Amgen: Dazodalibep Showed Statistically Significant & Clinically Meaningful Improvement in Systemic Disease Activity

THOMSON REUTERS
·
Sep 22

Amgen: Phase 3 Oasiz 303 Study of Dazodalibep in Moderate-to-Severe Symptomatic SjÖGren’s Disease Expected to Complete in Q4 2026

THOMSON REUTERS
·
Sep 22

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)

TIPRANKS
·
Sep 22

Sino Biopharmaceutical Stock Slips 1.4% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 22

Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 21

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 19

Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial

TIPRANKS
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

TIPRANKS
·
Sep 17

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)

TIPRANKS
·
Sep 17

Barclays Sticks to Its Hold Rating for Amgen (AMGN)

TIPRANKS
·
Sep 17

Analyst Maintains Buy on Amgen, Citing Resilient Fundamentals, Strong Execution, and Late-Stage Pipeline Upside

TIPRANKS
·
Sep 17

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

Reuters
·
Sep 16

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Reuters
·
Sep 16

Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17

Reuters
·
Sep 15